FOLH1 and Familial prostate cancer: 177Lu-PSMA-617 exhibited high stability for at least 72 h, high binding affinity towards PSMA (Ki = 6.91 ± 1.32 nM for natLu-PSMA-617) along with enhanced internalization rate into the LNCaP prostate cancer cells.